Related Experiment Video

Updated: Apr 16, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.9K

MicroRNAs-mediated cell fate in triple negative breast cancers

Xinbing Sui1, Xian Wang1, Weidong Han1

  • 1Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China; Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.

Cancer Letters
|March 10, 2015
PubMed

Insights

MicroRNAs (miRNAs) are crucial regulators in cell processes and cancer. Understanding their role in triple-negative breast cancer (TNBC) may lead to new therapeutic targets for this challenging disease.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
  • miRNAs are implicated in critical biological processes like cell survival, cell cycle, and differentiation.
  • Dysregulation of miRNAs contributes to cancer initiation and metastasis.

Purpose of the Study:

  • To highlight the significance of miRNAs in triple-negative breast cancer (TNBC).
  • To underscore the challenges in TNBC therapy due to its aggressive nature.
  • To emphasize the potential of miRNAs as therapeutic targets for TNBC.

Main Methods:

  • Review of current literature on miRNA function in cancer.
  • Analysis of the role of specific miRNAs in TNBC pathogenesis.
  • Correlation of miRNA expression with TNBC prognosis.

Main Results:

  • miRNAs are key players in various cellular functions relevant to cancer.
  • TNBC, characterized by the absence of ER, PR, and HER2/neu, poses a therapeutic challenge.
  • Several miRNAs have been identified to play crucial roles in TNBC and are linked to poor prognosis.

Conclusions:

  • Understanding novel miRNA functions is essential for advancing TNBC treatment.
  • miRNAs represent promising targets for developing novel therapeutic strategies for TNBC patients.
  • Further research into miRNA mechanisms can improve outcomes for TNBC.
Keywords:
Cell fateMicroRNATriple negative breast cancer

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K